Close and agile research collaboration sparks new thinking to better understand disease processes

GLAZgo Discovery Centre is a collaborative venture established by AstraZeneca and the University of Glasgow.
A key driver behind the collaboration was our desire to understand the processes of respiratory, inflammation and autoimmunity diseases in greater depth, in order to develop novel therapies that go beyond symptom control to helping us understand how to modify the disease process.
The agility of the partnership, coupled with the close working relationships between scientists from both sides, is unique among pharma industry collaborations.